Observational Study of the A&M Breathalyzer PROTECT Kiosk for COVID-19 Detection
This study is testing a new device called the A&M Breathalyzer PROTECT Kiosk. This device aims to passively detect COVID-19 by analyzing your breath. Researchers want to make sure the kiosk works well and can be used in different settings, especially for military personnel. You can join if you are between 18 and 89 years old, whether you have COVID-19 symptoms or not, and are already getting screened for COVID-19, Flu, or RSV at Brooke Army Medical Center (BAMC). The main goals are to optimize how the kiosk works and evaluate its breath capture system. This is an observational study, meaning researchers are watching and collecting information, not giving a new treatment. The study is planned to enroll 100 participants.
- Study design
- This is an observational study with no specified phase, aiming to enroll 100 participants. Researchers will collect breath readings from participants using the A&M Breathalyzer PROTECT Kiosk.
- What's involved
- You would provide breath samples using the A&M Breathalyzer PROTECT Kiosk. The study will run from enrollment through to study completion, which could be a minimum of 48 hours up to 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed from enrollment through to study completion, which could be a minimum of 48 hours up to 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Tony Yuan, PhD · PRINCIPAL_INVESTIGATOR · Uniformed Services University of the Health Sciences (USUHS)
- Michael Morris, MD · PRINCIPAL_INVESTIGATOR · Brooke Army Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Concentration on optimization and operationalizing the A&M Breathalyzer PROTECT KioskEnrollment through to study completion (min 48hrs through to 12 months)
Optimization and operationalize the A\&M Breathalyzer PROTECT Kiosk, to test its detection capabilities of COVID-19, Flu, and/or RSV among symptomatic and asymptomatic COVID-19, Flu or RSV carrier vs. those not infected compared to gold standard RT-PCR.
- Concentration on evaluating the passive sensing, breath capture system built within the A&M Breathalyzer PROTECT Kiosk.Enrollment through to study completion (min 48hrs through to 12 months)
This evaluation would conclude with a set of sensors and sensor inputs that would be analyzed by the Atomic AI platform built in the device. Field testing at BAMC is planned to determine the level of detection and discrimination for sensor combinations to SARS-CoV2 components and biomarkers detected. This testing would update the Atomic AI algorithm, within the device, to understand the accuracy of positive detection and the resulting sensitivities.